"Multiple Sclerosis Drug Repurposed as Promising Alzheimer's Therapy"

Ponesimod, an FDA-approved drug used to treat multiple sclerosis, has shown promise as a potential therapy for Alzheimer's disease. The medication reduces neuroinflammation, a key factor in Alzheimer's progression, by reprogramming microglia cells to clear toxic proteins. Experiments in mouse models and human brain samples support these findings, suggesting that ponesimod could be repurposed for Alzheimer's treatment.